gluformin 1000 mg 1000 mg/1 tableta filmom obložena tableta
pliva d.o.o.sarajevo - metformin - filmom obložena tableta - 1000 mg/1 tableta - 1 filmom obložena tableta sadrži: 1000 mg metforminhidrohlorid
gluformin 850 mg 850 mg/1 tableta filmom obložena tableta
pliva d.o.o.sarajevo - metformin - filmom obložena tableta - 850 mg/1 tableta - 1 filmom obložena tableta sadrži: 850 mg metforminhidrohlorid
gluformin 850 mg 850 mg/1 tableta filmom obložena tableta
pliva d.o.o.sarajevo - metformin - filmom obložena tableta - 850 mg/1 tableta - 1 filmom obložena tableta sadrži: 850 mg metforminhidrohlorid
gluformin 850 mg 850 mg/1 tableta filmom obložena tableta
pliva d.o.o.sarajevo - metformin - filmom obložena tableta - 850 mg/1 tableta - 1 filmom obložena tableta sadrži: 850 mg metforminhidrohlorid
gluformin 850 mg 850 mg/1 tableta filmom obložena tableta
pliva d.o.o.sarajevo - metformin - filmom obložena tableta - 850 mg/1 tableta - 1 filmom obložena tableta sadrži: 850 mg metforminhidrohlorid
desloratadine ratiopharm
ratiopharm gmbh - dcsloratadin - rhinitis, allergic, perennial; urticaria; rhinitis, allergic, seasonal - antihistaminici za sistemsku primjenu, - desloratadine ratiopharm is indicated in adults for the relief of symptoms associated with:allergic rhinitischronic idiopathic urticaria as initially diagnosed by a physician.
sitagliptin / metformin hydrochloride mylan
mylan ireland limited - sitagliptin hydrochloride monohydrate, metformin hydrochloride - dijabetes mellitus, tip 2 - lijekovi koji se koriste u dijabetesu - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride mylan is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride mylan is indicated in combination with a sulphonylurea (i. trostruki kombinovanu terapiju) kao dodatak prehrani i vježbe kod pacijenata, nedovoljno kontroliranim o njihovo maksimalno переносимой doze метформина i sulfonilurejom. sitagliptin/metformin hydrochloride mylan is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparg) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparg agonist. sitagliptin/metformin hydrochloride mylan is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.
momecutan 1 mg/g krema
mibe pharmaceuticals d.o.o., zavrtnica 17, zagreb, hrvatska - mometazonfuroat - krema - 1 mg/g - urbroj: 1 g kreme sadrži 1 mg mometazonfuroata
momecutan 1 mg/g mast
mibe pharmaceuticals d.o.o., zavrtnica 17, zagreb, hrvatska - mometazonfuroat - mast - 1 mg/g - urbroj: 1 g masti sadrži 1 mg mometazonfuroata
momecutan 1 mg/g otopina za kožu
mibe pharmaceuticals d.o.o., zavrtnica 17, zagreb, hrvatska - mometazonfuroat - otopina za kožu - 1 mg/g - urbroj: 1 g otopine za kožu (ekvivalent 1,07 ml) sadrži 1 mg mometazonfuroata